Hrstka R - Search Results

1

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.

Slaby O, Lakomy R, Fadrus P, Hrstka R, Kren L, Lzicarova E, Smrcka M, Svoboda M, Dolezalova H, Novakova J, Valik D, Vyzula R, Michalek J. Slaby O, et al. Among authors: hrstka r. Neoplasma. 2010;57(3):264-9. doi: 10.4149/neo_2010_03_264. Neoplasma. 2010. PMID: 20353279

2

[Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].

Slabý O, Krekác D, Hrstka R, Svoboda M, Vyzula R. Slabý O, et al. Among authors: hrstka r. Cas Lek Cesk. 2008;147(1):25-31. Cas Lek Cesk. 2008. PMID: 18323039 Review. Czech.

3

Significant overexpression of Hsp110 gene during colorectal cancer progression.

Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J, Smerdova T, Knoflickova D, Vyzula R. Slaby O, et al. Among authors: hrstka r. Oncol Rep. 2009 May;21(5):1235-41. doi: 10.3892/or_00000346. Oncol Rep. 2009. PMID: 19360299

4

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.

Grell P, Fabian P, Khoylou M, Radova L, Slaby O, Hrstka R, Vyzula R, Hajduch M, Svoboda M. Grell P, et al. Among authors: hrstka r. Int J Oncol. 2012 Oct;41(4):1204-12. doi: 10.3892/ijo.2012.1576. Epub 2012 Jul 27. Int J Oncol. 2012. PMID: 22842582 Free PMC article.

5

AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.

Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M. Hrstka R, et al. Dis Markers. 2013;35(4):207-12. doi: 10.1155/2013/761537. Epub 2013 Sep 3. Dis Markers. 2013. PMID: 24167368 Free PMC article.

6

Evaluation of cytotoxic activity of titanocene difluorides and determination of their mechanism of action in ovarian cancer cells.

Koubkova L, Vyzula R, Karban J, Pinkas J, Ondrouskova E, Vojtesek B, Hrstka R. Koubkova L, et al. Among authors: hrstka r. Invest New Drugs. 2015 Oct;33(5):1123-32. doi: 10.1007/s10637-015-0274-y. Epub 2015 Jul 24. Invest New Drugs. 2015. PMID: 26205069

7

MDM2SNP309 does not associate with elevated MDM2 protein expression or breast cancer risk.

Krekac D, Brozkova K, Knoflickova D, Hrstka R, Muller P, Nenutil R, Vojtesek B. Krekac D, et al. Among authors: hrstka r. Oncology. 2008;74(1-2):84-7. doi: 10.1159/000139135. Epub 2008 Jun 12. Oncology. 2008. PMID: 18547962

8

Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.

Hrstka R, Coates PJ, Vojtesek B. Hrstka R, et al. J Cell Mol Med. 2009 Mar;13(3):440-53. doi: 10.1111/j.1582-4934.2008.00634.x. J Cell Mol Med. 2009. PMID: 19379143 Free PMC article. Review.

9

Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.

Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, Nenutil R, Vojtesek B. Hublarova P, et al. Among authors: hrstka r. Int J Gynecol Cancer. 2009 Apr;19(3):321-5. doi: 10.1111/IGC.0b013e31819d8a5c. Int J Gynecol Cancer. 2009. PMID: 19407553

10

Second primary cancers - causes, incidence and the future.

Koubková L, Hrstka R, Dobes P, Vojtesek B, Vyzula R. Koubková L, et al. Among authors: hrstka r. Klin Onkol. 2014;27(1):11-7. doi: 10.14735/amko201411. Klin Onkol. 2014. PMID: 24635432 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters